维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Berrutti"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Efficacy of amoxicillinplus clavulanic acid -based triple therapy for Helicobacterpylori eradication:A retrospective study 显示文摘	Berrutti M Astegiano M Smedile A	2010	Pan Minerva Med2010，52，4：	1
	2	Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis显示文摘	Pellicano R Leone N Berrutti M		0，，04：	1
	3	Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis显示文摘	Pellicano R Leone N Berrutti M	2000	J Hepatol2000，33，4：	1
	4	Helicobacter pylori seroprevalence in hepatitis with cirrhosis C virus positive patients显示文摘	Rinaldo Pellicano Nicola Leone Mara Berrutti	2000	J Hepatol2000，33，：	1
	5	Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis显示文摘	Rinaldo Pellicano Nicola Leone Mara Berrutti	2000	J Hepatol2000，33，4：	1
	6	Endometrosis related to infertility显示文摘	Gianetto Berrutti A Feyles V	2003	Minerva Ginecol2003，55，5：	1
	7	Endometriosis related to infertility 显示文摘	Gianetto- Berrutti A F eyles V	2003	Minerva Ginecol2003，55，5：	1
	8	Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C显示文摘AIM: To compare the efficacy and safety of recombinant human IFN β-1a alone or in combination with ribavirin in treatment-na(i)ve subjects with chronic hepatitis C.METHODS: Open, randomized trial was performed in 6 Italian tertiary centers: 102 of the 108 patients screened were randomized to receive 6 MIU of recombinant human IFN β-1a subcutaneously daily for 24 wk, alone (Group 1, n = 51) or in combination with ribavirin 1 000 to 1 200 mg/d (Group 2, n = 51).RESULTS: The end-of-treatment virologic response rate was 29.4% in Group 1 and 41.2% in Group 2 (non-significant). Twenty-four weeks after stopping therapy,sustained virologic response rate was 21.6% in Group 1 and 27.4% in Group 2 (non-significant). All subjects in Group 1 completed treatment, while two subjects in Group 2 stopped therapy due to treatment-related adverse events.CONCLUSION: Recombinant human IFN β-1a, alone or in combination with ribavirin, has an excellent safety profile and, may represent an alternative for chronic hepatitis C patients who are unable to tolerate pegylated α-interferon.	Rinaldo Pellicano Antonio Craxì Piero Luigi Almasio Mario Valenza Giovanna Venezia Alfredo Alberti Silvia Boccato Luigi Demelia Orazio Sorbello Antonino Picciotto Francesco Torre Gaetano Ideo Carlo Cattaneo Mara Berrutti Mario Rizzetto	2005	World Journal of Gastroenterology2005，11，29：	1
	9	Endometrosis related to infertility显示文摘	Gianetto Berrutti A Feyles V	2003	Minerva Gineeol2003，55，5：	1
	10	Efficacy of amoxicillin plus clavulanic acid - based triple therapy for Helicobacter pylori eradication : a retrospective study 显示文摘	Berrutti M Astegiano M Smedile A	2010	Pan Minerva Med2010，52，4：	1
	11	Efficacy of amoxi- cillin plus clavulanic acid-based triple therapy for Heli- cobacter pylori eradication : a retrospective study 显示文摘	Berrutti M Astegiano M Smedile A	2010	Pan- minerva Med2010，52，4：	1
	12	Cardiac myxoma is rich in factor ⅩⅢa positive dendrophages: immunohistochemical study of four cases 显示文摘	Berrutti L Silverman J S	1996	Histopathology1996，28，6：	1
	13	Endometriosis related to infertility 显示文摘	Gianetto Berrutti A Feyles V	2003	Minerva Ginecol2003，55，3：	1
	14	Cardiac myxoma is rich in factor XIIIa positive dendrophages: immunohistochemical study of four cases 显示文摘	Berrutti L Silverman JS	1996	Histopathology1996，28，6：	1
	15	Efficacy of amoxicillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication:a retrospective study显示文摘	Berrutti M Astegiano M Smedile A		0，，04：	1
	16	Endometrosis related to infertility显示文摘	Gianetto Berrutti A Feyles V	2003	Minerva Ginecol2003，55，5：	1
	17	Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication:a retrospective study显示文摘	BERRUTTI M ASTEGIANO M SMEDILE A	2010	Panminerva Med2010，52，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费